info@aurevixpeptides.com
Illustrative vial: HexarelinHexarelin

Illustrative presentation

INFORMATIONAL REFERENCE

Hexarelin

Hexarelin is investigated in growth-hormone and CD36-related pathways. Preclinical work on cholesterol transport offers a mechanistic reason to study cardiovascular biology, without establishing clinical heart protection.

Research focus & potential applications

CD36 signaling
Cholesterol transport

What the research shows

Explore the selected studies, their findings and their limits.

Read the findings & sourcesPreclinical evidence

Experiments in macrophages found that hexarelin affected CD36-related signaling and cholesterol export. A related mouse model showed changes in atherosclerotic lesions. These mechanistic findings explain cardiovascular research interest, but they do not establish prevention of heart attacks, treatment of heart disease or a general fitness benefit in humans.

For more information, contact info@aurevixpeptides.com.

Editorial review: September 23, 2026